And CMC studies verifies the ability to formulate ABS-101 at high concentrations of 200 mg/ml, which supports further ...

UNI-494 was well-tolerated as a single dose up to 160 mg and in multiple doses at 40 mg twice-a-day ... Kidney Week 2024 ...

Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

Yet while MG Ultra makes a few slight gestures at a ... you can practically see him slamming a door covered in Serial Experiments Lain posters in their faces. The glitchy electronics of the ...

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...

Patient characteristics are consistent with other DLB studies -PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, ...

The combination of sitravatinib, nivolumab, and ipilimumab appears safe and active in patients with advanced clear cell renal cell carcinoma (ccRCC), according to research presented in a poster at ...

Abbisko announces positive results from phase 3 MANEUVER study of pimicotinib to treat tenosynovial giant cell tumour: Shanghai Wednesday, November 13, 2024, 18:00 Hrs [IST] Abbis ...